Wire · regulatory
Sanofi Commitments Put Vaccine Disparagement Inside EU Antitrust Enforcement
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 10 July 2026 · Fusion42 review
The EU Commission is enforcing competition law against Sanofi for allegedly disparaging a rival influenza vaccine (Fluad) through misleading promotional claims, securing binding commitments including corrective statements on company websites and restrictions on negative messaging until March 2030.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
EU competition enforcement now extends to pharmaceutical disparagement and misleading health communications; founders in healthtech/pharma must audit promotional claims and align with expert assessments or face Article 102 abuse investigations and binding commitments.
◆ Coverage
1 source · 9 Jul 2026
◆ Related on Wire
◆ Topics